Hervycta Plus 150 Injection 1's

Question 1

How does Hervycta Plus 150 Injection 1's work?

Accepted Answer

Hervycta Plus 150 Injection 1's contains Trastuzumab, which works by inhibiting the excess production of a protein called human epidermal growth factor receptor 2 (HER2) in mammalian cells. This causes inhibition of the cancer cell growth.

Question 2

What are the points to be informed to the doctor before starting treatment?

Accepted Answer

Inform your doctor whether you have received any other cancer treatment. Hervycta Plus 150 Injection 1's may cause a decrease in left ventricular ejection fraction, cardiomyopathy, hypersensitivity reactions, pulmonary toxicity, and embryo-fetal toxicity during the treatment. Hence, inform your oncologist if you have any cardiovascular conditions, liver/kidney disease, lung problems, are pregnant, are planning to become pregnant, or are breastfeeding before receiving Hervycta Plus 150 Injection 1's.

Welcome User

Hervycta Plus 150 Injection 1's

Eleftha 150 mg Injection 1's

Hervycta 150 Injection 1's

Hermab 150 mg Injection 7.2 ml

Trazumab 150 Injection 1's

Hersima 150 mg Injection 7.2 ml

Ontramab 150 mg Injection 7.2 ml

Herclon 150Mg Inj

Priunta 150 mg Injection 7.2 ml

Trumab 150 Injection 7.2 ml

Haltrust 150 Injection 1's